Senior Reporter
kay-marie.fletcher@guardian.co.tt
Despite concerns raised by pharmacy associations over medication shortages under the Chronic Disease Assistance Programme (CDAP), the Trinidad and Tobago Association of Retired Persons (TTARP) says it has not received complaints from its members about being unable to access their prescriptions.
TTARP first vice-president Reynold Cooper told Guardian Media the organisation has not been made aware of any widespread issues affecting retirees who depend on the programme.
“I haven’t heard anything. We have not received any reports from our members about medication shortages or difficulties accessing their prescriptions through CDAP,” Cooper said.
His comments came a day after Health Minister Dr Lackram Bodoe acknowledged ongoing supply chain and distribution challenges affecting the programme, while emphasising that patients should still be able to obtain medication elsewhere within the public health system.
Bodoe said pharmacists have been instructed to contact neighbouring health centres and pharmacies to locate medications when stocks are unavailable at their facilities. He added that the Ministry of Health is working to address both distribution and broader supply chain issues.
During an Opposition media conference on Wednesday, PNM deputy political leader Dr Sanjiv Boodhu also raised concerns over reports of medication shortages.
He called on the Government to address shortages of drugs available under CDAP.
The Association of Pharmacist Owned Pharmacies has also complained that shortages of several commonly prescribed medications, including rosuvastatin, losartan, amlodipine and metformin, have persisted since late last year, forcing some patients to purchase medication privately when CDAP stocks are unavailable.
Meanwhile, the Private Pharmacy Retail Business Association agreed that while distribution challenges exist, the larger issue has been the supply of medication from pharmaceutical distributors, a situation it said has been exacerbated by delayed Government payments.
The association noted that payments have resumed in recent months and expressed optimism that supplies will improve during the August distribution cycle.
Despite those concerns from pharmacy providers, there appears to be no widespread indication that patients are experiencing difficulties accessing medication.
Guardian Media also spoke with members of the public, who likewise reported no problems obtaining prescriptions through the CDAP programme.
